Jeffrey Cislini

Jeffrey Cislini

General Counsel and SecretaryatRevolution Medicines· In proxies 2023–2025

Pay in FY2025+36% from the year before · Revolution Medicines stock +82.1% the same year

Jeffrey Cislini was paid $3.7M in FY2025 (Dec), up 36%. Revolution Medicines stock rose 82.1% that year.

Pay$100 in the stock at the end of FY22 → $334
Pay is from the Summary Compensation Table of each Revolution Medicines proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Revolution MedicinesPublic company · 3 yr
    • General Counsel and Secretary2023 – Present · 3 yrStock in role +758%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?